[1]古丽娜孜·肉孜,穆妮热·排尔哈提,海力里·麦麦提,等.基于骨筋肌三位一体中医药防治原发性骨质疏松症的研究进展[J].西部中医药,2023,36(06):137-140.[doi:10.12174/j.issn.2096-9600.2023.06.33]
　Gulinazi·Rouzi,Munire·Paierhati,Hailili·Maimaiti,et al.Research Progress of Preventing and Treating Primary Osteoporosis with TCM Based on the Trinity of Bone, Sinew and Muscle[J].Western Journal of Traditional Chinese Medicine,2023,36(06):137-140.[doi:10.12174/j.issn.2096-9600.2023.06.33]
点击复制

基于骨筋肌三位一体中医药防治原发性骨质疏松症的研究进展
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年06期
页码:
137-140
栏目:
出版日期:
2023-06-15

文章信息/Info

Title:
Research Progress of Preventing and Treating Primary Osteoporosis with TCM Based on the Trinity of Bone, Sinew and Muscle
作者:
古丽娜孜·肉孜, 穆妮热·排尔哈提, 海力里·麦麦提, 买买提明·努尔买买提, 阿衣努尔·买提斯迪克
新疆医科大学维吾尔医学院，新疆 乌鲁木齐 830011
Author(s):
Gulinazi·Rouzi , Munire·Paierhati , Hailili·Maimaiti , Maimaitiming·Nuermaimaiti , Ayinuer·Maitisidike
Institute of Traditional Uighur Medicine, Xinjiang Medical University, Urumqi 830011, China
关键词:
中医中药; 原发性骨质疏松症; 骨; 筋; 肌肉; 中医防治
Keywords:
TCM; primary osteoporosis; bone;  sinew and muscle; TCM prevention and treatment
分类号:
R274
DOI:
10.12174/j.issn.2096-9600.2023.06.33
文献标志码:
A
摘要:
中医学认为，原发性骨质疏松症（primary osteoporosis，POP），虽为骨骼疾病，但其病程与骨、筋、肌三者密不可分。因此以“骨、筋、肌”三位一体理论为基础，从三者之间的关系、发病机理、治疗、预防等方面进行论述，希望为POP的中医临床防治提供新的思路及参考，进而体显中医整体观在POP研讨中的作用。
Abstract:
TCM holds that primary osteoporosis (POP) belongs to bone disease, its course is closely related to bone, sinew and muscle. Therefore, on the foundation of the trinity theory of bone, sinew and muscle, the paper states the relationship between them, pathogenesis, treatment and the prevention, hoping to provide new thinking and reference for TCM clinical prevention and treatment of POP, thereby embodying the functions of TCM holism in POP research.

相似文献/References:

[1]李政.徐凤芹治疗不稳定型静息性心绞痛经验小结[J].西部中医药,2014,27(08):24.
　LI Zheng.A Summary of Xu Fengqin′s Experience of Treating Unstable Resting Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2014,27(06):24.
[2]曾昭洋,胡文斌,魏学玲,等.中老年人原发性骨质疏松症与中医体质类型的Logistic回归分析[J].西部中医药,2018,31(02):66.
　ZENG Zhaoyang,HU Wenbin,WEI Xueling,et al.Logistic Regression Analysis of Middle-aged and Elderly People with Primary Osteoporosis and TCM Constitution Types[J].Western Journal of Traditional Chinese Medicine,2018,31(06):66.
[3]梁浩东,潘碧琦,杨伟毅,等.刘军教授治疗肌肉劳损的用药规律研究[J].西部中医药,2018,31(03):64.
　LIANG Haodong,PAN Biqi,YANG Weiyi,et al.Research on Professor Liu Jun′s Administration Laws of Treating Muscular Strain[J].Western Journal of Traditional Chinese Medicine,2018,31(06):64.
[4]孙竹清,蔡正生,郑基永.补肾健脾壮骨方联合钙尔奇D治疗脾肾两虚型原发性骨质疏松症的疗效及对CaM、TGF-β1的影响[J].西部中医药,2022,35(09):99.[doi:10.12174/j.issn.2096-9600.2022.09.19]
　SUN Zhuqing,CAI Zhengsheng,ZHENG Jiyong.Clinical Effects of Tonifying-kidney-spleen Strengthening-bone Prescription and Caltrate D in the Treatment of Primary Osteoporosis of Spleen-kidney Dual Deficiency Pattern and Its Influence on the Levels of CaM and TGF-β1[J].Western Journal of Traditional Chinese Medicine,2022,35(06):99.[doi:10.12174/j.issn.2096-9600.2022.09.19]
[5]姚力,张雪莲.围绝经期综合征中医治疗现状[J].西部中医药,2022,35(10):154.[doi:10.12174/j.issn.2096-9600.2022.10.34]
　YAO Li,ZHANG Xuelian.Current Situation of TCM Therapies for Perimenopausal Syndrome[J].Western Journal of Traditional Chinese Medicine,2022,35(06):154.[doi:10.12174/j.issn.2096-9600.2022.10.34]
[6]蒋云霞,罗伟生.理气药治疗肝纤维化作用的研究进展[J].西部中医药,2023,36(04):133.[doi:10.12174/j.issn.2096-9600.2023.04.31]
　JIANG Yunxia,LUO Weisheng.Research Progress of Regulating-Qi Drugs in the Treatment of Liver Fibrosis[J].Western Journal of Traditional Chinese Medicine,2023,36(06):133.[doi:10.12174/j.issn.2096-9600.2023.04.31]
[7]刘文佳,刘宗凯,初晓苏,等.基于网络药理学探讨青蒿鳖甲汤及补中益气汤治疗癌性发热的“同病异治”分子作用机制[J].西部中医药,2023,36(07):20.[doi:10.12174/j.issn.2096-9600.2023.07.05]
　LIU Wenjia,LIU Zongkai,CHU Xiaosu,et al.Network Pharmacology-based Discussion on Molecular Mechanism of "Different Treatment of the Same Disease" in the Treatment of Cancerous Fever by Qinghao Bijia Tang and Buzhong Yiqi Tang[J].Western Journal of Traditional Chinese Medicine,2023,36(06):20.[doi:10.12174/j.issn.2096-9600.2023.07.05]
[8]王江静,刘国强,潘浩,等.基于生物信息学方法探讨骨质疏松症不同病因病机的治疗要点[J].西部中医药,2024,37(07):50.[doi:10.12174/j.issn.2096-9600.2024.07.13]
　WANG Jiangjing,LIU Guoqiang,PAN Hao,et al.The Treatment Points for Osteoporosis with Different Causes and Pathogenesis Based on Bioinformatics Methods[J].Western Journal of Traditional Chinese Medicine,2024,37(06):50.[doi:10.12174/j.issn.2096-9600.2024.07.13]

备注/Memo

备注/Memo:
古丽娜孜·肉孜（1983—），女，硕士学位，主治医师。研究方向：骨质疏松症的发病机理。国家自然科学基金地区基金（81660831）。
更新日期/Last Update: 2023-06-15